As far as the PI3K pathway is concerned, mutations of the well-known oncogene, PIK3CA, occur far more frequently in HPV(+) HNSCC than in EBV(+) NPC (Table 3; 36% cases vs. 4% cases, respectively). This evidence concerns the gene PIK3CB and head and neck squamous cell carcinoma.